Geller Advisors LLC Astrazeneca PLC Transaction History
Geller Advisors LLC
- $1.44 Billion
- Q3 2024
A detailed history of Geller Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Geller Advisors LLC holds 16,649 shares of AZN stock, worth $1.13 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
16,649
Previous 16,603
0.28%
Holding current value
$1.13 Million
Previous $1.29 Million
0.23%
% of portfolio
0.09%
Previous 0.1%
Shares
16 transactions
Others Institutions Holding AZN
# of Institutions
1,351Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.27 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.85 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.53 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.5 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.3 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $211B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...